Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

Fig. 4

Serial changes in PFWT (a), WBFPS (b), ABI (c), and TcPO2 (d) after PBDSCs transplantation. Comparison of the serial changes in PFWT (e), WBFPS (f), ABI (g), and TcPO2 (h) between the PCCs and PBMNCs groups. PBDSCs, peripheral blood-derived stem cells. PCCs, purified CD34+ cells; PBMNCs, peripheral blood mononuclear cells, PFWT, pain-free walking time; WBFPS, Wong-Baker faces pain rating scale; ABI, ankle-brachial index; TcPO2, transcutaneous pressure of oxygen. *P < .05 compared with the baseline; **P < .01 compared with the baseline; P < .05 compared between two groups; ‡‡P < .01 compared between two groups

Back to article page